Liposomal bupivacaine is a novel local anesthetic designed for prolonged pain relief. Despite
its long-acting analgesic potential, liposomal bupivacaine is significantly more expensive
than other local anesthetic alternatives. The primary aim of this investigation is to examine
whether or not liposomal bupivacaine provides superior pain relief or clinically significant
opioid-sparing effects versus a control to justify its cost.
Phase:
Phase 4
Details
Lead Sponsor:
Miller Orthopedic Specialists
Collaborators:
CHI Health Mercy Hospital Creighton University Medical Center